KK
Kristen Kluska Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ultragenyx Pharmaceutical
RARE
$3.08B
| $32.01 | $105 |
228%
upside
| Overweight | 6 hours ago |
|
2
PTC Therapeutics
PTCT
$4.62B
| $58.17 | $118 |
103%
upside
| Overweight | 2 days ago |
|
3
Monopar Therapeutics
MNPR
$257M
| $41.63 | $74 |
78%
upside
| Overweight | 9 days ago |
|
4
Supernus Pharmaceuticals
SUPN
$2.58B
| $45.98 | $46 |
0%
upside
| Overweight | 1 month ago |
|
5
Rigel Pharmaceuticals
RIGL
$723M
| $40.32 | $32 |
21%
downside
| Neutral | 1 month ago |
|
6
Zevra Therapeutics
ZVRA
$498M
| $8.88 | $29 |
227%
upside
| Overweight | 1 month ago |
|
7
Solid Biosciences
SLDB
$435M
| $5.58 | $16 |
187%
upside
| Overweight | 3 months ago |
|
8
Fulcrum Therapeutics
FULC
$418M
| $7.73 | $10 |
29%
upside
| Overweight | 3 months ago |
|
9
Capricor Therapeutics
CAPR
$303M
| $6.63 | $30 |
352%
upside
| Overweight | 3 months ago |
|
10
Sarepta Therapeutics
SRPT
$1.97B
| $18.85 | $81 |
330%
upside
| Overweight | 4 months ago |
|
11
Taysha Gene Therapies
TSHA
$922M
| $3.38 | $7 |
107%
upside
| Overweight | 4 months ago |
|
12
Soleno Therapeutics
SLNO
$3.65B
| $68.77 | $123 |
79%
upside
| Overweight | 5 months ago |
|
|
MREO
13
Mereo BioPharma
MREO
$280M
| $1.76 | $7 |
298%
upside
| Overweight | 5 months ago |
|
14
Disc Medicine
IRON
$2.14B
| $61.59 | $132 |
114%
upside
| Overweight | 5 months ago |
|
15
ADMA Biologics
ADMA
$4.04B
| $16.92 | $25 |
48%
upside
| Overweight | 6 months ago |
|
16
Celldex Therapeutics
CLDX
$1.55B
| $23.30 | $67 |
188%
upside
| Overweight | 7 months ago |
|
17
Amicus Therapeutics
FOLD
$2.52B
| $8.16 | $21 |
157%
upside
| Overweight | 7 months ago |
|
18
89bio
ETNB
$1.29B
| $8.67 | $29 |
234%
upside
| Overweight | 8 months ago |
|
19
Aquestive Therapeutics
AQST
$657M
| $5.43 | $17 |
213%
upside
| Overweight | 8 months ago |
|
20
Esperion Therapeutics
ESPR
$536M
| $2.66 | $8 |
201%
upside
| Overweight | 8 months ago |
|
21
uniQure
QURE
$985M
| $17.96 | $58 |
223%
upside
| Overweight | 8 months ago |
|
22
Abeona Therapeutics
ABEO
$354M
| $6.91 | $18 |
160%
upside
| Overweight | 10 months ago |
|
23
Lineage Cell Therapeutics
LCTX
$281M
| $1.23 | $6 |
388%
upside
| Overweight | 1 year ago |
|
24
Alpha Tau Medical
DRTS
$301M
| $3.54 | $23 |
550%
upside
| Overweight | 2 years ago |
|
|
BTX
25
BlackRock Technology and Private Equity Term Trust
BTX
$818M
| $7.01 | $180 |
2,468%
upside
| Overweight | 3 years ago |
|